Literature DB >> 26097597

Interleukin-10 promotor -592A/C polymorphism is associated with slow coronary flow in Han Chinese.

Gui-Liang Shi1, Xing-Xing Cai2, Ya-Min Su2, Chu Chen2, Xin-Tao Deng1, Hai-Yan Pan2, Meng-Kan Fan1, Jian-Hua Zhu1, Min Pan1.   

Abstract

An accumulating body of evidence suggests that slow coronary flow (SCF) phenomenon seems to be an early-form of atherosclerosis and low-grade inflammation plays a major role in the atherosclerotic vascular processes. Interleukin (IL)-10 is a multifunctional cytokine involved in both innate and adaptive immune response. The aim of the present study is to investigate the association of IL-10 gene -592A/C polymorphism with SCF in Han Chinese. 250 patients who underwent coronary angiography and had angiographically normal coronary arteries of varying coronary flow rates without any atherosclerotic lesion were enrolled in this study. Patients who had thrombolysis in myocardial infarction frame counts (TFC) above the normal cutoffs were considered to have SCF and those within normal limits were considered to have normal coronary flow (NCF). The PCR-based restriction fragment length polymorphism (PCR-RFLP) technique was used to assess the genotypes frequencies. The distribution of the IL-10 -592A/C genotypes (AA, AC, and CC) was 46.34%, 41.46%, and 12.20% in the NCF group, and 66.51%, 28.71%, and 4.78% in SCF subjects, respectively (P = 0.0280). The frequency of the A allele in the SCF group was significantly higher than that in the NCF group (80.86% vs. 67.07%, P = 0.0054). Compared with the CC genotype, the AA genotype had increased risk of SCF in both unadjusted and adjusted analyses. In SCF patients, the average serum IL-10 levels in AA genotype were statistically lower than in AC + CC genotype (P = 0.0000). These findings suggest that IL-10 -592A/C polymorphism is associated with SCF and the A allele has increased risk for SCF in Han Chinese.

Entities:  

Keywords:  Chinese; Slow coronary flow; coronary artery disease; genetic polymorphism; interleukin-10

Mesh:

Substances:

Year:  2015        PMID: 26097597      PMCID: PMC4466984     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  47 in total

1.  Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever.

Authors:  Enver Sancakdar; Ahmet Sami Güven; Elif Bilge Uysal; Ali Kaya; Köksal Deveci; Hekim Karapınar; Ismail Akkar
Journal:  Int J Clin Exp Med       Date:  2014-03-15

2.  Polymorphisms of interferon-gamma gene CA-repeat and interleukin-10 promoter region (-592A/C) in Japanese type I diabetes.

Authors:  Hisataka Tegoshi; Goji Hasegawa; Hiroshi Obayashi; Koji Nakano; Yoshihiro Kitagawa; Michiaki Fukui; Satoshi Matsuo; Masako Deguchi; Mitsuhiro Ohta; Masataka Nishimura; Naoto Nakamura; Toshikazu Yoshikawa
Journal:  Hum Immunol       Date:  2002-02       Impact factor: 2.850

3.  Is slow coronary flow associated with inflammation?

Authors:  Jian-Jun Li; Bo Xu; Zi-Cheng Li; Jie Qian; Bing-Qi Wei
Journal:  Med Hypotheses       Date:  2005-11-08       Impact factor: 1.538

4.  Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis.

Authors:  Dolores López-Maderuelo; Francisco Arnalich; Rocio Serantes; Alicia González; Rosa Codoceo; Rosario Madero; Juan J Vázquez; Carmen Montiel
Journal:  Am J Respir Crit Care Med       Date:  2003-01-16       Impact factor: 21.405

5.  Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus.

Authors:  C C Mok; J S Lanchbury; D W Chan; C S Lau
Journal:  Arthritis Rheum       Date:  1998-06

6.  Intereleukin-10 promoter polymorphism in mild cognitive impairment and in its clinical evolution.

Authors:  Beatrice Arosio; Luigina Mastronardi; Carlo Vergani; Giorgio Annoni
Journal:  Int J Alzheimers Dis       Date:  2010-07-20

7.  Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study.

Authors:  Murtaza Emre Durakoğlugil; Sinan Altan Kocaman; Mustafa Çetin; Aynur Kirbaş; Aytun Canga; Turan Erdoğan; Yüksel Çiçek
Journal:  Anadolu Kardiyol Derg       Date:  2012-10-12

8.  Association of angiotensin-converting enzyme gene 2350G>A polymorphism with myocardial infarction in a Chinese population.

Authors:  Min-Hui Jiang; Mei-Fang Wei; Zhi-Hua Liu; Wen-Ping Jiang; Hai-Hua Geng; Zhi-Chu Cui; Dong-Lei Zhang; Jian-Hua Zhu
Journal:  Clin Appl Thromb Hemost       Date:  2008-04-28       Impact factor: 2.389

9.  Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension.

Authors:  Min Pan; Jian-Hua Zhu; Zhi-Hua Liu; Wen-Ping Jiang; Zhi-Chu Cui; Xiao-Hong Yu; Hong-Mei Li; Xiang-Jun Yang
Journal:  Hypertens Res       Date:  2007-01       Impact factor: 3.872

10.  Association of Interleukin-10 gene promoter polymorphisms in Saudi patients with vitiligo.

Authors:  Abdullah Abanmi; Fahad Al Harthi; Abdulrahman Zouman; Aida Kudwah; Mohammed Al Jamal; Misbahul Arfin; Mohammad Tariq
Journal:  Dis Markers       Date:  2008       Impact factor: 3.434

View more
  3 in total

1.  Endothelial nitric oxide synthase Asp298Glu (894G/T) gene polymorphism as a possible risk factor for the coronary slow flow phenomenon among Iranians.

Authors:  Yeganeh Karimi; Fatemeh Sehati; Ali Sarreshtedari; Mina Mirzad; Yasaman Khalili; Reza Kiani; Elham Taheri Bajgan; Maryam Hosseini Moghadam; Farzaneh Mehrvarz; Hooman Bakhshandeh; Maryam Parham; Mahshid Malakootian; Parham Sadeghipour
Journal:  BMC Cardiovasc Disord       Date:  2022-06-30       Impact factor: 2.174

2.  Association of Interleukin-1 Gene cluster polymorphisms with coronary slow flow phenomenon.

Authors:  Ferit Onur Mutluer; Dilek Ural; Barış Güngör; Osman Bolca; Tolga Aksu
Journal:  Anatol J Cardiol       Date:  2018-01       Impact factor: 1.596

3.  Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.

Authors:  Yao-Dong Ding; Yu-Qiang Pei; Rui Wang; Jia-Xing Yang; Yin-Xin Zhao; Xiao-Li Liu; Hua Shen; Qian Ma; Shuo Zhang; Hai-Long Ge
Journal:  BMC Cardiovasc Disord       Date:  2020-05-27       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.